aromasil has been researched along with homocysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anker, GB; Johannessen, DC; Lien, EA; Lonning, PE; Refsum, H; Ueland, PM | 1 |
| di Salle, E; Eide, GE; Geisler, J; Hagen, AI; Krag, LE; Lien, EA; Løkkevik, E; Lønning, PE; Ofjord, ES; Paolini, J; Polli, A; Risberg, T; Schlichting, E | 1 |
1 trial(s) available for aromasil and homocysteine
| Article | Year |
|---|---|
Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study.
Topics: Androstadienes; Aromatase Inhibitors; Biomarkers; Blood Coagulation Factors; Bone and Bones; Bone Density; Bone Remodeling; Breast Neoplasms; Female; Follow-Up Studies; Gonadal Steroid Hormones; Homocysteine; Humans; Lipids; Middle Aged; Postmenopause; Vitamin D; Withholding Treatment | 2006 |
1 other study(ies) available for aromasil and homocysteine
| Article | Year |
|---|---|
Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Creatinine; Enzyme Inhibitors; Estrogen Antagonists; Homocysteine; Humans; Postmenopause; Vitamins | 1999 |